Prince Akwasi Mensah

Array ( [id] => 5638068 [patent_doc_number] => 20060069042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Cytochrome P450 2C9 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/948206 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7149 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069042.pdf [firstpage_image] =>[orig_patent_app_number] => 10948206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188729 [patent_doc_number] => 20050192348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Methods and products which utilize N-acyl-L-aspartic acid' [patent_app_type] => utility [patent_app_number] => 10/949715 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21019 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192348.pdf [firstpage_image] =>[orig_patent_app_number] => 10949715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255639 [patent_doc_number] => 20050075371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Methods and compositions for the oral administration of prodrugs of proton pump inhibitors' [patent_app_type] => utility [patent_app_number] => 10/943411 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8326 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075371.pdf [firstpage_image] =>[orig_patent_app_number] => 10943411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205707 [patent_doc_number] => 20070027189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Use of known active ingredients as radical scavengers' [patent_app_type] => utility [patent_app_number] => 10/571570 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3994 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027189.pdf [firstpage_image] =>[orig_patent_app_number] => 10571570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612860 [patent_doc_number] => 07148258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 10/941242 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6874 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148258.pdf [firstpage_image] =>[orig_patent_app_number] => 10941242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034263 [patent_doc_number] => 20050032773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositons comprising them and their use in the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 10/941190 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6923 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032773.pdf [firstpage_image] =>[orig_patent_app_number] => 10941190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607499 [patent_doc_number] => 07098217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => '3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/935961 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14006 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098217.pdf [firstpage_image] =>[orig_patent_app_number] => 10935961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991517 [patent_doc_number] => 20050090554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists' [patent_app_type] => utility [patent_app_number] => 10/935176 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16651 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090554.pdf [firstpage_image] =>[orig_patent_app_number] => 10935176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127960 [patent_doc_number] => 20050059704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions useful for treating gastrointestinal motility disorders' [patent_app_type] => utility [patent_app_number] => 10/928624 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19932 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059704.pdf [firstpage_image] =>[orig_patent_app_number] => 10928624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207332 [patent_doc_number] => 20050043355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/928835 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11174 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043355.pdf [firstpage_image] =>[orig_patent_app_number] => 10928835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127975 [patent_doc_number] => 20050059719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Solid dosage formulation containing a Factor Xa inhibitor and method' [patent_app_type] => utility [patent_app_number] => 10/924043 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6466 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059719.pdf [firstpage_image] =>[orig_patent_app_number] => 10924043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097730 [patent_doc_number] => 20050130189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Compositions and methods for treating and diagnosing irritable bowel syndrome' [patent_app_type] => utility [patent_app_number] => 10/923035 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 45248 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130189.pdf [firstpage_image] =>[orig_patent_app_number] => 10923035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330278 [patent_doc_number] => 20040254248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Method of treatment and/or prophylaxis of ulcers' [patent_app_type] => new [patent_app_number] => 10/483392 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4442 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254248.pdf [firstpage_image] =>[orig_patent_app_number] => 10483392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206211 [patent_doc_number] => 20050043239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods of inhibiting immune responses stimulated by an endogenous factor' [patent_app_type] => utility [patent_app_number] => 10/918803 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17770 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043239.pdf [firstpage_image] =>[orig_patent_app_number] => 10918803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442536 [patent_doc_number] => 07928132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Methods for the amelioration of episodes of acute or chronic ulcerative colitis' [patent_app_type] => utility [patent_app_number] => 10/912948 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20321 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928132.pdf [firstpage_image] =>[orig_patent_app_number] => 10912948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786902 [patent_doc_number] => 20060205819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Methods of treatment inflammatory bowel with lxr agonists' [patent_app_type] => utility [patent_app_number] => 10/566637 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17409 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205819.pdf [firstpage_image] =>[orig_patent_app_number] => 10566637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769496 [patent_doc_number] => 20060020045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods and compositions for treating inflammatory disorders of the gastrointestinal tract' [patent_app_type] => utility [patent_app_number] => 10/898896 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7555 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020045.pdf [firstpage_image] =>[orig_patent_app_number] => 10898896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 420368 [patent_doc_number] => RE039861 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-09-25 [patent_title] => 'Methods of extended use oral contraception' [patent_app_type] => reissue [patent_app_number] => 10/893795 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2804 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039861.pdf [firstpage_image] =>[orig_patent_app_number] => 10893795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971360 [patent_doc_number] => 20050037070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them' [patent_app_type] => utility [patent_app_number] => 10/893203 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21043 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037070.pdf [firstpage_image] =>[orig_patent_app_number] => 10893203 [rel_patent_id] =>[rel_patent_doc_number] =>)